Cancer Research UK, a charity funded by private donations, says Chinese researchers have found that cancerous cells can regenerate long after normal ones have been irrevocably damaged by apoptosis.
Research published in the British Journal of Cancer by scientists at the University of Hong Kong details studies in which human cervical, skin, liver and breast cancer cells were treated with three distinct chemicals that cause apoptosis- jasplakinolide, staurosporine and ethanol.
Once the cells had been treated beyond the point at which normal ones would be unable to heal from the damage caused by the agents, they were removed. However, the cancerous cells were able to regain their shape, function and ability to divide. Only once the nucleus of the cancerous cells had begun to disintegrate was apoptosis assured.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze